Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytokinetics Inc (NASDAQ:CYTK)

14.10
Delayed Data
As of May 26
 +0.05 / +0.36%
Today’s Change
7.94
Today|||52-Week Range
17.20
+16.05%
Year-to-Date
No recent news for Cytokinetics Inc.

Today’s Trading

Previous close14.05
Today’s open14.05
Day’s range13.95 - 14.30
Volume574,412
Average volume (3 months)574,650
Market cap$686.3M
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-738.46%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+271.30%
P/E ratio176.3
Price/Sales4.86
Price/Book6.07

Competitors

 Today’s
change
Today’s
% change
BYSIBeyondspring Inc-0.13-0.39%
OMEROmeros Corp-0.14-0.88%
HSKAHeska Corp-0.57-0.58%
KERXKeryx Biopharmaceuti...+0.04+0.62%
Data as of 3:59pm ET, 05/26/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.59
Annual revenue (last year)$106.4M
Annual profit (last year)$16.5M
Net profit margin15.46%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Robert I. Blum
Chief Financial Officer, Secretary &
Executive VP
Barabari Sharon A. Surrey
Corporate headquarters
South San Francisco, California

Forecasts